EAM
AMED

Eagle Asset Management’s Amedisys AMED Stock Holding History

Eagle Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-238,971
Closed -$41.2M – 562
2022
Q1 		$41.2M Buy
238,971
+3,718
+2% +$555K 0.21% 147
2021
Q4 		$38.6M Sell
235,253
-57,132
-20% -$9.18M 0.17% 164
2021
Q3 		$43.6M Sell
292,385
-2,228
-0.8% -$463K 0.2% 164
2021
Q2 		$72.2M Sell
294,613
-177
-0.1% -$46.4K 0.31% 123
2021
Q1 		$79.4M Sell
294,790
-148,672
-34% -$41.9M 0.35% 108
2020
Q4 		$130M Sell
443,462
-47,161
-10% -$12.1M 0.73% 30
2020
Q3 		$114M Sell
490,623
-49,561
-9% -$11.3M 0.59% 52
2020
Q2 		$107M Buy
540,184
+234,411
+77% +$43.7M 0.61% 47
2020
Q1 		$56.1M Buy
305,773
+17,981
+6% +$3.2M 0.35% 107
2019
Q4 		$48M Sell
287,792
-2,160
-0.7% -$321K 0.23% 167
2019
Q3 		$38M Sell
289,952
-1,290
-0.4% -$168K 0.2% 177
2019
Q2 		$35.4M Buy
+291,242
New +$34.6M 0.18% 199

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Eagle Asset Management's AMED Position: Q2 2022 in Review

Eagle Asset Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 238,971 shares — an estimated $41.2M sold.

Eagle Asset Management first reported a position in AMED in Q2 2019 and held it in 12 quarters. The position peaked at $130M in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Eagle Asset Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Eagle Asset Management sold 238,971 Amedisys shares in Q2 2022, an estimated $41.2M.
  • Eagle Asset Management first reported a position in Amedisys in Q2 2019 and held it in 12 quarters.
  • Eagle Asset Management's Amedisys position peaked at $130M in Q4 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Eagle Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.